Business, News Omeros’ Lead MASP-3 Inhibitor OMS906 Demonstrates Blockade of the Alternative Pathway of Complement System by Business Wire • 2016/08/04 • 0 Comments SEATTLE--(BUSINESS WIRE)--Omeros’ Lead MASP-3 Inhibitor OMS906 Demonstrates Blockade of the Alternative Pathway of Complement System
